Aardvark Therapeutics (AARD) vs Biomea Fusion (BMEA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Biomea Fusion (BMEA) has outperformed Aardvark Therapeutics (AARD) over the past year, losing 18.5% versus a loss of 72.5%. Aardvark Therapeutics is the larger company by market cap ($103.1 million vs $99.1 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AARD | BMEA |
|---|---|---|
| Share price | $4.71 | $1.37 |
| Market cap | $103.08M | $99.05M |
| 1-day change | -5.04% | +3.79% |
| YTD return | -64.11% | +10.48% |
| 1-year return | -72.50% | -18.45% |
| 5-year return | — | -88.22% |
| EPS (TTM) | $-3.21 | $-0.29 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $17.23 | $2.24 |
| 52-week low | $3.35 | $0.872 |
| Distance from 52-week high | -72.66% | -38.76% |
| Average volume | 209.46K | 1.47M |
| Shares outstanding | 21.88M | 72.30M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BMEA has outperformed AARD by 54.1 percentage points over the past year.
AARD vs BMEA FAQ
Which is bigger, Aardvark Therapeutics or Biomea Fusion?
Aardvark Therapeutics (AARD) is larger, with a market capitalization of $103.08M compared with $99.05M for Biomea Fusion (BMEA).
Which stock has performed better over the past year, AARD or BMEA?
BMEA returned -18.45% over the past 12 months, compared with -72.50% for AARD (price return, excluding dividends). Past performance does not predict future results.
Are Aardvark Therapeutics and Biomea Fusion in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.